Adverse Drug Reaction News Bulletins
ADR News Bulletin 2020 September (Volume 22 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 September 2020
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Conditional approval of remdesivir (Veklury®) for COVID-19 infection in Singapore
Temporary suspension of sales of Esmya™ (ulipristal acetate) Tablet 5mg
Risk of venous thromboembolism with tofacitinib
Risk of orofacial malformations associated with the use of ondansetron in early pregnancy
AE Case in Focus: Test Yourself - What could have caused the acute kidney injury in this patient?
Click on the link below to download the issue in PDF: